CAMP Q1 2024 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$13M

Net Income

-$12M

EPS (Diluted)

$-1.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$856,000

Balance Sheet

Total Assets

$30M

Total Liabilities

$15M

Stockholders' Equity

$15M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$79M	-100.0%
Gross Profit	$0	$28M	-100.0%
Operating Income	-$13M	-$2M	-715.4%
Net Income	-$12M	-$8M	-53.9%